Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Baylor College of Medicine
Eisai Inc.
City of Hope Medical Center
M.D. Anderson Cancer Center
Sotio Biotech Inc.
GlaxoSmithKline
SOLTI Breast Cancer Research Group